Stocks · Healthcare · Medical - Specialties
Shoulder Innovations, Inc. SI
$19.01 +1.39% Close, Oct 2, 2026 · NYSE · Market cap $394.2M
Strong growthLow risk
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -58.5% from -47.1% a year earlier.
- Revenue over the last four quarters was $60.1M, up 60.9% from a year earlier, accelerating from 55.9% a quarter earlier.
- The stock is in an uptrend: above its 200-day average for 84 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 14%
- Revenue growth accelerationTop 18%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 46%
- Gross marginTop 34%
- Operating marginBottom 34%
- Accruals (lower is better)Bottom 15%
- Interest coverBottom 19%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 48%
- Free-cash-flow yieldBottom 34%
- EBITDA / enterprise valueBottom 42%
- Sales / enterprise valueBottom 42%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 25%
- 6-month returnTop 32%
- 1-year return vs S&P 500Top 24%
- Distance from 52-week highTop 36%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 36%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetBottom 29%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 38%
- Maximum drawdown, 3 yearsTop 5%
- Beta vs S&P 500 (lower is better)Top 1%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 55.9% | 60.9% | ↑ |
| Gross margin | 73.1% | 77.3% | ↑ |
| Operating margin | -47.1% | -58.5% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 60.9% | 55.9% | ↑ | Top 14% |
| Gross margin | 77.3% | 73.1% | ↑ | Top 34% |
| Operating margin | -58.5% | -47.1% | ↓ | Bottom 34% |
| Net margin | -58.3% | -84.9% | ↑ | — |
| Free-cash-flow margin | -78.4% | — | — | |
| Return on invested capital | -25.3% | — | Bottom 46% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 1.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 4.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -3.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -37.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.29%
- Shareholder yield
- -0.29%
- Share count change, 1 year
- +1.8%
- Share count change, 3-year CAGR
- +1.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 2 of 5
- Average EPS surprise, last 4
- -3.4%
- Average 2-day reaction, last 8
- -0.9%
- Positive 20 days after report
- 3 of 5
Analysts
- Consensus price target
- $23.50
- Target vs current price
- +23.6%
- Analysts with a rating
- 4
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | -0.3% | -0.8% | -14.4% | -8.7% | — |
| May 13, 2026 | +6.8% | +1.2% | +11.7% | +33.8% | +54.0% |
| Mar 10, 2026 | +9.5% | -2.5% | +14.1% | +8.3% | +3.3% |
| Nov 11, 2025 | -29.7% | +3.2% | +31.4% | +35.6% | +15.7% |
| Sep 9, 2025 | -10131.7% | -5.8% | -6.0% | -17.7% | -4.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.46 | -$0.46 | -0.3% | $17.2M |
| May 13, 2026 | -$0.41 | -$0.44 | +6.8% | $16.7M |
| Mar 10, 2026 | -$0.38 | -$0.42 | +9.5% | $14.4M |
| Nov 11, 2025 | -$0.48 | -$0.37 | -29.7% | $11.8M |
| Sep 9, 2025 | -$0.64 | -$0.01 | -10131.7% | $11.0M |
| Jul 9, 2025 | -$0.24 | — | — | $10.1M |
| Dec 31, 2024 | -$0.19 | — | — | $8.7M |
| Sep 30, 2024 | -$0.20 | — | — | $7.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 6.40× | — | — | Bottom 42% |
| Free-cash-flow yield | -11.94% | — | — | Bottom 34% |
| Earnings yield | -9.00% | — | — | Bottom 48% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 84
- 50-day average slope (20 days)
- -5.3%
- 200-day average slope (20 days)
- +2.2%
- Distance from 50-day average
- -6.2%
- Distance from 200-day average
- +14.5%
- RSI (14)
- 50.7
- Relative volume
- 1.06×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 62.2%
- Beta vs S&P 500 (2 years, weekly)
- -0.50
- Correlation with S&P 500
- -0.08
- Current drawdown from 1-year high
- -21.6%
- Maximum drawdown, 3 years
- -31.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 2, 2025 | Nov 10, 2025 | -31.3% | 49 days | 12 days (Nov 26, 2025) |
| Jul 28, 2026 | Sep 25, 2026 | -29.9% | 42 days | Not yet recovered |
| Dec 16, 2025 | Feb 11, 2026 | -25.3% | 38 days | 82 days (Jun 10, 2026) |
| Jul 31, 2025 | Aug 20, 2025 | -19.6% | 14 days | 5 days (Aug 27, 2025) |
| Jun 26, 2026 | Jul 10, 2026 | -11.5% | 9 days | 12 days (Jul 28, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $394.2M
- EPS, diluted (TTM)
- -$1.71
- Revenue (TTM)
- $60.1M
- 52-week range
- $10.92 – $24.60
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Revenue | $19.3M | $31.6M | $47.3M |
| Gross profit | $15.3M | $24.3M | $36.2M |
| Operating income | -$10.9M | -$14.7M | -$26.3M |
| Net income | -$12.7M | -$15.6M | -$40.4M |
| EPS (diluted) | -$0.63 | -$0.77 | -$1.96 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5M | $8.7M | $10.1M | $11.0M | $11.8M | $14.4M | $16.7M | $17.2M |
| Net income | -$4.1M | -$3.8M | -$4.7M | -$19.2M | -$8.7M | -$7.8M | -$8.4M | -$10.2M |
| EPS (diluted) | -$0.20 | -$0.19 | -$0.23 | -$0.95 | -$0.43 | -$0.38 | -$0.41 | -$0.49 |
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Operating cash flow | -$13.1M | -$14.1M | -$28.6M |
| Capital expenditure | -$2.7M | -$4.0M | -$7.4M |
| Free cash flow | -$15.9M | -$18.2M | -$36.0M |
| Dividends paid | $0 | $0 | $0 |
| Net share buybacks | $0 | $66,000 | $65.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $99.0M
- Total assets
- $152.0M
- Total liabilities
- $27.7M
- Total debt
- $14.8M
- Net debt
- -$9.6M
- Shareholders’ equity
- $124.3M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 419,759
- Days to cover
- 4.69
- Change vs previous report
- +39.2%
FINRA short interest, settlement date Sep 15, 2026.